Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Tunica Albuginea who wrote (5861)	3/11/1998 12:40:00 AM
From: RT	Read Replies (1) \| Respond to of 23519

<<RT, I agree with Eye DrMike. It will take two weeks or 3 at most for a patient to figure out the pill doesn't work for them.>> Tunica, I agree, the average patient should know if the pill works for them after two to three weeks. However, what will happens to demand if Viagara captures 50% of Muse users. In less than a few weeks, Vivus could possibly lose half of it's customer base. To make matters worse, this will happen just when they acquire excess capacity. RT